Medicare

Federal data reports that U.S. prescription drug prices fell 3.1% from a year ago, marking the steepest year-over-year drop since 1963. Although the White House credits these price declines to Trump's drug deals, experts note that other factors are potentially more significant contributors. These complex factors include Medicare negotiations allowed by the Inflation Reduction Act and increased market competition from generic or biosimilar drugs.

Recent federal data shows that U.S. prescription drug prices declined 3.1% from a year ago, the steepest drop since 1963. While Donald Trump has taken credit for these drops through “most favored nation” deals, experts suggest other factors are equally significant. These contributors include competition from generic and biosimilar products, as well as policy changes like the Inflation Reduction Act's allowance for Medicare to negotiate drug costs.

U.S. prescription drug prices declined 3.1% from a year ago, marking the steepest drop since 1963. Although President Donald Trump claims credit via 'most favored nation' deals, experts note the price reduction is complex. Contributing factors include Medicare's ability to negotiate costs through policies like the Inflation Reduction Act, and market competition fueled by generic and biosimilar drugs.

As midterm elections approach, various political labels are used to categorize candidates, with 'democratic socialist' gaining significant attention. The article defines democratic socialists as those who seek to regulate capitalism while maintaining democracy, contrasting them with socialists who favor sharing ownership of the means of production. Examples cited include Zohran Mamdani and Abdul El-Sayed.

Voters in Wisconsin are weighing candidates' stances regarding cuts or expansion of Medicare and Medicaid. Bill Hogseth canvassed door-to-door in western Wisconsin, speaking with strangers about his own seizures and their resulting impacts. He also asked voters to share stories about their experiences with ambulance rides or hospital bills.

House Republicans hope that efforts to crack down on alleged abuse in safety-net programs will revive talks of tackling fraud before year's end. However, skepticism remains about whether any such bill will reach the president’s desk due to impending midterms and lack of immediate success. The article notes that achieving legislative goals requires intervention from Vice President Vance or President Trump.

Governor Kathy Hochul condemned the end of a Medicare subsidy program designed to keep prescription drug premiums lower for seniors in New York. The Centers for Medicare and Medicaid Services announced the conclusion of this program, which had started in 2024 under the Biden Administration.

Mark Sanford, a former South Carolina governor, has entered the race to replace Senator Lindsey Graham. He emphasizes concerns about the national debt and government efficiency, citing his past experience in reducing DMV wait times. Sanford also reflects on lessons learned from a 2009 marital scandal and his subsequent return to public office.

Changing how Medicare pays for hospice care could save the U.S. $7.6 billion annually, but concerns remain about potential impacts on patient care. The hospice industry argues the current payment system enables providers to create individualized care plans tailored to patients’ specific needs.

Excluding rare disease treatments from Medicare drug-pricing pilots would eliminate significant savings, according to a Harvard University researcher. Biotech companies are lobbying the Trump administration to exclude these treatments from the Global Benchmark for Efficient Drug Pricing (GLOBE) and Guarding U.S. Medicare Against Rising Drug Costs (GUARD) pilots, which aim to lower drug prices to levels in other wealthy nations.

The article discusses common scams targeting elderly individuals, including fraudulent calls from purported representatives of Medicare and Spectrum. Scammers often request personal information or access to devices, exploiting victims' lack of technical knowledge. The author expresses confusion about the legitimate process for receiving Medicare benefits.

Abdul El-Sayed is running a campaign in Michigan with a platform opposing Israel, advocating for ICE abolition, increasing taxes on the wealthy, and expanding Medicare to all Americans.

Vice President JD Vance will host a meeting with members of Congress at the White House to discuss legislative action on fraud. The task force, led by Vance, is targeting healthcare fraud schemes and has suspended over $1.4 billion in federal funding for suspected providers. The Justice Department recently expanded its Northeast Health Care Fraud Strike Force to Philadelphia.

The DOJ has charged 19 individuals in Philadelphia with $4 million in Medicare and Medicaid fraud. Federal and state authorities are expanding the Northeast Health Care Fraud Strike Force to the area to target such fraud.

A new analysis questions the justification for expanded exemptions of orphan drugs from Medicare pricing negotiations under the Orphan Cures Act, which broadened protections for drugs with multiple rare disease indications. The law delays price negotiation timelines for these drugs, despite concerns they may not warrant such exemptions.

Medicare is eliminating alternative pathways that allowed FDA-designated 'breakthrough' medical devices to qualify for supplemental payments without proving clinical improvement. The Centers for Medicare and Medicaid Services finalized a rule requiring such devices to demonstrate substantial clinical improvement starting in fiscal year 2028.

A teenager caused a T-bone collision, leaving the author injured. The author's car lacked collision coverage, raising concerns about whether Medicare will cover hospital expenses.

Stein and DHHS are urging federal health officials to reverse a CMS rule that conflicts with Congress' intent to protect healthcare for vulnerable populations, risking health care loss for North Carolinians using Medicaid and Medicare.

Medicare will end a subsidy program that reduced prescription drug plan premiums, as insurers can now price plans accurately without it. The Centers for Medicare & Medicaid Services (CMS) claims premiums will rise by less than $10 for most recipients, with some seeing lower costs. The subsidy, which averaged a $16 reduction, supported Medicare Part D plans offered through private insurers like UnitedHealth Group, Humana, and Aetna.

Teva Pharmaceuticals CEO Richard Francis discussed the company's positive Q2 earnings, the impact of changing Medicare rules on patients, and the new direct listing on the NYSE with Bloomberg reporter Romaine Bostick.

New York City sued two Brooklyn dental providers for allegedly exploiting patients by misrepresenting costs, pressuring them into unnecessary procedures, and enrolling them in high-interest loans without consent. The lawsuit targets New York Family Dentistry and Canarsie Family Dentistry, accusing them of violating consumer protection laws and preying on vulnerable communities, including elderly and low-income individuals.

Humana, a health insurer, reduced its annual profit forecast to at least $6.52 per share from $8.36 due to lower Medicare ratings affecting bonuses.

The Trump administration is exploring alternatives to the current Medicare physician payment system based on fee-for-service. The Centers for Medicare issued a request for information on July 14 to evaluate potential changes.

The article describes frequent unsolicited phone calls from numbers sharing the same first six digits, differing by one digit in the area code/exchange. Callers, likely several counties away, attempt to sell Medicare Advantage plans, with the recipient suspecting the calls are part of a telemarketing scheme during a Special Enrollment Period.

An individual working beyond 70 plans to retire at the end of their 70th year and transition to Medicare. They question whether working past 70 will increase their Social Security benefits.

CMS evaluated one year of health tech progress and announced eight new pledge categories. A symbolic event at Health and Human Services headquarters featured a coffin labeled 'RIP CLIPBOARD' to signify the decline of traditional paper-based healthcare practices.

Sturgis Hospital in Michigan, which converted to a federal emergency-focused model to save rural hospitals, closed after three years, highlighting concerns about the model's effectiveness under the One Big Beautiful Bill Act. The law includes a $50 billion Rural Health Transformation Program but faces criticism for potentially disadvantaging rural hospitals amid expected Medicaid funding cuts.

Eli Lilly's obesity drug retatrutide showed significant weight loss in a Phase 3 study but did not reduce cardiovascular risk. The U.S. Medicare program is offering injectable GLP-1 obesity medications like Wegovy, Foundayo, and Zepbound through a trial program for $50 monthly, with high patient demand for injectables despite expectations of pill preference.

Medicare Part D, which provides prescription drug coverage, has a 2026 average monthly premium of $34.50, a maximum annual deductible of $615, and an out-of-pocket cap of $2,100. The Inflation Reduction Act of 2022 limits insulin copays to $35 per month, and Part D covers 10 specific drugs with reduced costs. Coverage is structured through tiered pricing and stages, including deductible, initial coverage, and catastrophic phases.

The Senate Health Committee, led by Republicans, advanced legislation to cap insulin costs at $35/month despite GOP objections. Maine Republican Susan Collins sponsored the bill, which aims to lower costs for diabetes patients. The bill passed 17-5, with bipartisan support but opposition from Chair Bill Cassidy.

The Trump administration's Office of Personnel Management plans to collect medical records of millions of federal workers and retirees, pseudonymizing data by removing names and Social Security numbers to detect fraud in health programs. The initiative faces criticism from privacy advocates and Senator Mark Warner, who argue it lacks sufficient privacy protections.

Virginia hospitals reported an 8% increase in ER visits by uninsured patients last year, attributed to federal healthcare shifts and reduced primary care access. State lawmakers allocated funding for free clinics and a new subsidy to address ACA subsidy expirations, while 13 rural hospitals face closure risks due to Medicare/Medicaid reimbursement cuts and expired subsidies.

Khalid Satary, a foreign national, was arrested for allegedly orchestrating a $547 million Medicare fraud scheme involving unnecessary genetic tests and kickbacks. He operated diagnostic labs from 2016 to 2019 and fled the U.S. in 2022 before being captured in the Middle East in 2026 with a fake Mexican passport.

A federal CMS pilot program offers limited coverage of three GLP-1 weight-management medications for qualifying Metro Nashville retirees on Medicare or Medicare Advantage. The program, separate from Metro’s health plan, requires a $50 monthly copay and mandates prescriptions be processed through a CMS system, not Metro’s plan. Vanderbilt University is studying the drugs’ potential for asthma and obesity.

Novo Nordisk sued Eli Lilly, alleging deceptive advertising claims about its weight-loss drug Zepbound compared to Novo Nordisk's Wegovy. The lawsuit claims Eli Lilly's ads use outdated clinical trials comparing different doses and mislead consumers into believing Zepbound is superior. Eli Lilly has defended its advertising and intends to contest the lawsuit.

Sen. Andy Kim introduced the MediKids Act, a proposal to automatically enroll every child in Medicare at birth and provide coverage until age 26. The act aims to expand healthcare access for children and young adults.

Biotech companies are lobbying the Trump administration to exclude rare disease treatments from Medicare price-lowering pilots. The Rare Disease Company Coalition met with the White House Office of Management and Budget to discuss exemptions from Trump’s plan to align U.S. drug prices with those in other countries through a most-favored nation policy.

Retirees selling highly appreciated homes may face higher Medicare premiums due to income-related monthly adjustment amounts (IRMAA). Large home sales can temporarily spike taxable income, pushing retirees into higher IRMAA brackets years later. Financial experts advise planning home sales before age 63 or using IRS capital gains exclusions to mitigate this risk.

Medicare covers CBD and hemp products through a limited pilot program called the Substance Access Beneficiary Engagement Incentive (BEI), allowing eligible beneficiaries to receive up to $500 annually in products containing 0.3% or less THC. Eligibility requires a physician in an ACO or EOM and state-specific legal access.

The article discusses the SEC's proposal to eliminate quarterly financial reports, which has received over 200,000 public comments, and Medicare's recent outpatient rule that includes cuts to drugs under the 340B discount program. The Centers for Medicare and Medicaid Services also reinforced a policy hospitals oppose.